Home > Pressrelease > Colposcopy Market size to surpass $747 Mn by 2032

Colposcopy Market size to surpass $747 Mn by 2032

  • Published Date: March 30, 2023

Colposcopy Market size is projected to cross USD 747 million by 2032, according to a new research report by Global Market Insights Inc.

The high prevalence of cervical cancer among older women will proliferate the demand for colposcopy procedures. A study conducted by researchers at the UC Davis Comprehensive Cancer Center revealed an upsurge in late-stage cervical cancer diagnoses among women aged 65 years and above in California. With the rapid rise in the elderly population and awareness about the impact of gynecological diseases, health spending is likely to rise.

Ease of installation & other features stimulate development of optical colposcopy systems

Colposcopy market from the optical product segment was valued at over USD 226.5 million in 2022, owing to the emphasis on early diagnosis of cervical cancer. Colposcopes with high-precision optics are being rapidly developed to offer reliable functioning support in cervical surgery applications. The ease of installation, low maintenance, distinct gradations, superior zoom and focus, wide view, and other key features will thus contribute to the adoption of optical colposcopes over the forecast period, states the report.

Handheld colposcopes gain preference over stationary alternatives due to high versatility

The market share from the handheld segment is poised to register over 3% CAGR through 2032, on account of the growing product preference over stationary counterparts. Advanced handheld colposcopes can also offer enhanced clinical services, simple interfaces, superior monitoring capabilities, and improved workflow.

Furthermore, extended battery life, versatility, anti-fogging capabilities, and other advantages associated with handheld colposcope devices will strengthen the industry outlook, the report claims.

Colposcope equipment to emerge as suitable solution for early diagnosis of oral mucosa lesions

The colposcopy market size from the oral area of diagnosis segment will exhibit over 2% CAGR from 2023-2032, given the capability to select more representative biopsy sites than routine clinical examinations. Colposcopes can also aid the early diagnosis of malignant and premalignant lesions of the oral mucosa such as oral squamous cell carcinoma and uvula-related conditions. The use of the product for oral mucosal lesion diagnosis will further rise due to benefits such as ease of use, versatility, precision, and non-invasiveness.

Browse key industry insights spread across 160 pages with 216 market data tables & 13 figures & charts from the report, “Colposcopy Market Size By Product (Optical, Digital), By Mobility (Fixed, Portable, Handheld), By Area of Diagnosis (Pelvic, Oral), By End-use (Hospitals, Clinics, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:

Rise in cervical cancer screenings to augment colposcope usage in diagnostic centers

 The diagnostic centers segment accounted for a 27% share of the colposcopy market in 2022, considering the increasing demand for cervical disease treatments. Cervical cancer, for example, has become common cancer among women. Over the years, the rate of colposcopy screenings has surged across Brazil, the report indicates. These factors, alongside the high awareness of early disease diagnosis, are expected to boost cervical cancer screenings in diagnostic centers over the forthcoming years.

Increase in geriatric population to proliferate colposcope equipment sales in Europe

Europe colposcopy industry will be valued at over USD 105 million by 2032, as a result of the growing awareness about early cancer diagnosis and increased disease prevalence. In addition, the rising population of geriatric people susceptible to cervical cancer will also drive the development of colposcopes across the region.

Advanced product launch strategies to influence the market landscape

The strategic landscape of the colposcopy market comprises companies such as MobileODT, Lutech, Seiler Instrument Inc., Olympus Corporation, Carl Zeiss, CooperSurgical Inc., ATMOS MedizinTechnik GmbH & Co KG, Karl Kaps, DYSIS Medical, and MedGyn, among others.

Authors: Sumant Ugalmugle, Rupali Swain